Cargando…
High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide
Amyloid beta (Aβ) peptides, in particular Aβ42 and Aβ40, exert neurotoxic effects and their overproduction leads to amyloid deposits in the brain, thus constituting an important biomolecular target for treatments of Alzheimer's disease (AD). We describe the engineering of cognate Anticalins as...
Autores principales: | Rauth, Sabine, Hinz, Dominik, Börger, Michael, Uhrig, Markus, Mayhaus, Manuel, Riemenschneider, Matthias, Skerra, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888463/ https://www.ncbi.nlm.nih.gov/pubmed/27029347 http://dx.doi.org/10.1042/BCJ20160114 |
Ejemplares similares
-
Anticalin(®) Proteins as Therapeutic Agents in Human Diseases
por: Rothe, Christine, et al.
Publicado: (2018) -
Development of a high affinity Anticalin(®) directed against human CD98hc for theranostic applications
por: Deuschle, Friedrich-Christian, et al.
Publicado: (2020) -
Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
por: Deuschle, Friedrich‐Christian, et al.
Publicado: (2020) -
Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins
por: Achatz, S., et al.
Publicado: (2021) -
Structure of the human heterodimeric transporter 4F2hc-LAT2 in complex with Anticalin, an alternative binding protein for applications in single-particle cryo-EM
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2022)